The Great 2023 Humira Biosimilars Watch Is On – Here’s Where to Focus
Up to 10 competing products for Humira are on the way in 2023. What should health plans and plan sponsors be following as the biosimilars landscape takes shape?
Up to 10 competing products for Humira are on the way in 2023. What should health plans and plan sponsors be following as the biosimilars landscape takes shape?
Some lesser-known facts about this chronic condition underscore the importance of medication adherence, and the positive impact RxSS can have on members with diabetes.
The Inflation Reduction Act has the potential to lower prescription drug costs for millions of Americans and raise them for millions more. Who stands to gain or lose?
We know many members are scrambling to find pharmacies with the common ADHD medication in stock. With this and other drug shortages, RxSS can be an invaluable resource.
A wave of FDA-approved biosimilars for Humira and other costly biologics will enter the U.S. market in 2023. What does it mean for patients, payers and plan designs?
Members shouldn’t confuse our clinical suggestions for intervention. Medication decisions are between patient and doctor. RxSS informs those discussions, and makes it easy to make a change.
Free PBM tools can help members get more from their pharmacy benefits, maybe even save on certain prescriptions. What more can you ask for? Quite a bit, actually.
Utilization of specialty medications continues to rise, and so do costs for patients and plan sponsors. Thanks to these rising costs, we see more plans choosing to implement copay adjustment programs, but it’s crucial to understand how they fit into your benefit and where they improve or hinder your plan.
Every May we raise awareness about mental health as we continue to help our members stay adherent by showing them affordable options for the medications they need.
Many point benefits solutions have produced positive results for employers and health plans. However, their full potential depends on medication access and affordability.